Supplementary Table 1 from Immune Consequences of Decreasing Tumor Vasculature with Antiangiogenic Tyrosine Kinase Inhibitors in Combination with Therapeutic Vaccines
Year: 2023
Type: supplementary-materials
Abstract: Effect of sunitinib alone, rMVA-Twist-TRICOM vaccine alone, or sunitinib in combination with vaccine on the phenotype of tumor-infiltrating MDSCs and TAMs in the 4T1 breast tumor model.
Language: English
Topic: Immune cells in cancer
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W4362551113